Transaction #24411 · Form 4 · 0001193125-25-331189
NEKTAR THERAPEUTICS · Stock award · Stock Option
NEKTAR THERAPEUTICS · Transacted December 22, 2025 · Filed December 23, 2025
What does this filing report?
An SEC Form 4 filing for NEKTAR THERAPEUTICS records a stock award involving Stock Option on December 22, 2025. The reported quantity was 25,000. The filing date is December 23, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- NEKTAR THERAPEUTICS
- Company CIK
- 0000906709
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 25,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 25,000
- Ownership description
- Not reported
- SEC acceptance time
- Dec 23, 2025, 6:01 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Zalevsky Jonathan ↗
Chief R&D Officer
CIK 0001789857
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 25,000
- Conversion / exercise price
- 43.48
- Exercise date
- Not reported
- Expiration date
- December 21, 2033
Filing footnotes & remarks
- F1
- Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs vest over four years from the date of grant (December 22, 2025) in substantially equal quarterly installments based on continued service.
- F2
- Stock options vest over four years from the date of grant, (December 22, 2025) in substantially equal monthly installments based on continued service.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.